Le facteur 4 plaquettaire, cible des anticorps anti-héparine : application au diagnostic biologique de la thrombopénie induite par l'héparine (TIH) = Platelet factor 4, target of heparin-dependent antibodies. Application for the biological diagnostic of heparin-Induced thrombocyto-peniaAMIRAL, J.Annales de médecine interne (Paris). 1997, Vol 148, Num 2, pp 142-149, issn 0003-410XConference Paper

Rôle du facteur plaquettaire 4 (PF4) dans les thrombopénies induites par l'héparine = Role of PF4 in heparin-induced thrombocytopeniaAMIRAL, J; MEYER, D.STV. Sang thrombose vaisseaux. 1995, Vol 7, Num 8, pp 549-555, issn 0999-7385Article

Modified antithrombin III levels during normal pregnancy and relationship with prothrombin fragment F₁₊₂ and thrombin-antithrombin complexesREBER, G; AMIRAL, J; DE MOERLOOSE, P et al.Thrombosis research. 1998, Vol 91, Num 1, pp 45-47, issn 0049-3848Article

Diagnostic approach of phospholipid-dependent antibodies : State-of-the art lectureAMIRAL, J.Haemostasis. 1999, Vol 29, Num 2-3, pp 135-149, issn 0301-0147Conference Paper

Plasma thrombomodulin concentrations in relation to cardiovascular risk factors in a population sampleNILSSON, T. K; HELLSTEN, G; AMIRAL, J et al.Blood coagulation & fibrinolysis. 1993, Vol 4, Num 3, pp 455-458, issn 0957-5235Article

An enzyme-linked immunosorbent assay for heparin cofactor II (HCII). Application to the measurement of HCII in clinical materialsTOULON, P; COSTA, J. M; AMIRAL, J et al.Clinica chimica acta. 1992, Vol 205, Num 1-2, pp 65-73, issn 0009-8981Article

Circulating endothelial cell/leucocyte adhesion molecules in ischaemic heart diseaseBLANN, A. D; AMIRAL, J; MCCOLLUM, C. N et al.British journal of haematology. 1996, Vol 95, Num 2, pp 263-265, issn 0007-1048Article

Heparin-induced thrombocytopenia : diagnostic tests and biological mechanismsAMIRAL, J; MEYER, D.Baillière's clinical haematology. 1998, Vol 11, Num 2, pp 447-460, issn 0950-3536Article

Prognostic value of increased soluble thrombomodulin and increased soluble E-selectin in ischaemic heart diseaseBLANN, A. D; AMIRAL, J; MCCOLLUM, C. N et al.European journal of haematology. 1997, Vol 59, Num 2, pp 115-120, issn 0902-4441Article

Preparation of factor-VIII-depleted plasma with antibodies and its use for the assay of factor VIIIROTHSCHILD, C; AMIRAL, J; ADAM, M et al.Haemostasis. 1990, Vol 20, Num 6, pp 321-328, issn 0301-0147, 8 p.Article

Protein C level at birthPOLACK, B; POUZOL, P; AMIRAL, J et al.Thrombosis and haemostasis. 1984, Vol 52, Num 2, pp 188-191, issn 0340-6245Article

Thrombomodulin levels during normal pregnancy, at delivery and in the postpartum : Comparison with tissue-type plasminogen activator and plasminogen activator inhibitor-1DE MOERLOOSE, P; MERMILLOD, N; AMIRAL, J et al.Thrombosis and haemostasis. 1998, Vol 79, Num 3, pp 554-556, issn 0340-6245Article

The influence of age, gender and ABO blood group on soluble endothelial cell markers and adhesion moleculesBLANN, A. D; DALY, R. J; AMIRAL, J et al.British journal of haematology. 1996, Vol 92, Num 2, pp 498-500, issn 0007-1048Article

Research and development strategies in hemostasis and thrombosisAMIRAL, J.Haematologica (Roma). 1995, Vol 80, Num 2, pp 14-24, issn 0390-6078, SUPConference Paper

Hyperhomocyst(e)inemia and endothelial dysfunction in IDDMHOFMANN, M. A; AMIRAL, J; HENKELS, M et al.Diabetes care. 1998, Vol 21, Num 5, pp 841-848, issn 0149-5992Article

One-step assay for the determination of free protein S antigen in plasma using real-time biospecific interaction analysisRAVANAT, C; WIESEL, M.-L; SCHUHLER, S et al.Blood coagulation & fibrinolysis. 1998, Vol 9, Num 4, pp 333-341, issn 0957-5235Article

Longitudinal study on activated factors XII and VII levels during normal pregnancyDE MOERLOOSE, P; AMIRAL, J; VISSAC, A.-M et al.British journal of haematology. 1998, Vol 100, Num 1, pp 40-44, issn 0007-1048Article

Soluble adhesion molecules, endothelial markers and atherosclerosis risk factors in abdominal aortic aneurysm : a comparison with claudicants and healthy controlsBLANN, A. D; DEVINE, C; AMIRAL, J et al.Blood coagulation & fibrinolysis. 1998, Vol 9, Num 6, pp 479-484, issn 0957-5235Article

Association of lupus anticoagulant with transient antibodies to prothrombin in a patient with hypoprothrombinemiaAMIRAL, J; ARONIS, S; ADAMTZIKI, E et al.Thrombosis research. 1997, Vol 86, Num 1, pp 73-78, issn 0049-3848Article

Hyperhomocyst(e)inemia and endothelial dysfunction in IDDMHOFMANN, M. A; KOHL, B; NAWROTH, P. P et al.Diabetes care. 1997, Vol 20, Num 12, pp 1880-1886, issn 0149-5992Article

Carboxyterminal peptides with the dimeric form of PF4 retain the inhibitory effect on the growth of human megakaryoblastic cell linesLEBEURIER, I; RACLET, L; AMIRAL, J et al.The Journal of laboratory and clinical medicine. 1996, Vol 127, Num 2, pp 179-185, issn 0022-2143Article

Population correlates of coagulation factor VII : Importance of age, sex, and menopausal status as determinants of activated factor VIISCARABIN, P.-Y; VISSAC, A.-M; KIRZIN, J.-M et al.Arteriosclerosis, thrombosis, and vascular biology. 1996, Vol 16, Num 9, pp 1170-1176, issn 1079-5642Article

Vascular endothelial lesion in patients undergoing bone marrow transplantationRICHARD, S; SEIGNEUR, M; BLANN, A et al.Bone marrow transplantation (Basingstoke). 1996, Vol 18, Num 5, pp 955-959, issn 0268-3369Article

Clinical applications of a direct assay of free protein S antigen using monoclonal antibodies: a study of 59 casesWOLF, M; BOYER-NEUMANN, C; PEYNAUD-DEBAYLE, E et al.Blood coagulation & fibrinolysis. 1994, Vol 5, Num 2, pp 187-192, issn 0957-5235Article

Levels of plasma thrombomodulin are increased in atheromatous arterial diseaseSEIGNEUR, M; DUFOURCQ, P; CONRI, C et al.Thrombosis research. 1993, Vol 71, Num 6, pp 423-431, issn 0049-3848Article